Clostridium difficile (C.diff) is a Gram-positive bacterium, which causes gastrointestinal infections in vulnerable hospitalized patients.
While information and literature pertaining to C.diff epidemiology is accumulating in Western markets, a lot less is known in large emerging nations such as China. Information is required to understand whether the extent of disease epidemiology and associated dynamics is similar to the West, and which steps need to be taken in order to accurately assess current disease burden.
This DiseaseINFOPACK is a comprehensive up-to-date review of current literature, also capturing the viewpoint of local physicians. It is designed to support the information gathering of commercial manufacturers of C.diff related therapies and immunotherapies who may wish to consider building a market development strategy in this region. The report has been written by a highly experienced expert author (Tenured US Professor level, MD/Ph.D) who trained in China and is knowledgeable in C.diff, vaccinology/local issues.